The dorsal raphe-to-ventral hippocampal projection modulates reactive aggression through 5-HT1B receptors.

Maladaptive reactive aggression is a core symptom of neuropsychiatric disorders such as schizophrenia. While uncontrolled aggression dampens societal safety, there is a limited understanding of the neural regulation involved in reactive aggression and its treatment. High levels of aggression have been linked to low serotonin (5-HT) levels. Additionally, post-weaning socially isolated (SI) mice exhibit outbursts of aggression following encountering acute stress, and hyperactivated ventral hippocampus (vHip) involves this stress-provoked escalated aggression. Here, we investigated the potential role of the raphe nucleus projecting to the vHip in modulating aggressive behavior. Chemogenetically activating the dorsal raphe nucleus (DRN) soma projecting the vHip or DRN nerve terminals in the vHip reduced reactive aggression. The reduction of attack behavior was abolished by the pretreatment of 5-HT 1B receptor antagonist SB-224289. However, activating the median raphe nucleus (MRN)-to-vHip pathway ameliorated depression-like behavior but did not affect reactive aggression. DRN→vHip activation suppressed the vHip downstream area, the ventromedial hypothalamus (VMH), which is a core aggression area. Intra-vHip infusion of 5-HT 1B receptor agonists (anpirtoline, CP-93129) suppressed reactive aggression and decreased c-Fos levels in the vHip neurons projecting to the VMH, suggesting an inhibition mechanism. Our findings indicate that activating the DRN projecting to the vHip is sufficient to inhibit reactive aggression in a 5-HT 1B receptor-dependent manner. Thus, targeting 5-HT 1B receptor could serve as a promising therapeutic approach to ameliorate symptoms of reactive aggression. [Display omitted] • Activation of DRN-to-vHip projection reduces reactive aggression. • Activation of MRN-to-vHip projection does not affect reactive aggression. • The DRN-mediated reduction in aggression is blocked by 5-HT 1B receptor antagonists. • Activation of 5-HT 1B receptors in the vHip suppresses the vHip-to-VMH projection. [ABSTRACT FROM AUTHOR]